These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 24920797)

  • 1. Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.
    Kocher J; Bui T; Giri-Rachman E; Wen K; Li G; Yang X; Liu F; Tan M; Xia M; Zhong W; Jiang X; Yuan L
    J Virol; 2014 Sep; 88(17):9728-43. PubMed ID: 24920797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.
    Malm M; Tamminen K; Lappalainen S; Uusi-Kerttula H; Vesikari T; Blazevic V
    Clin Vaccine Immunol; 2015 Jun; 22(6):656-63. PubMed ID: 25903355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin Reduces Protection and Intestinal T Cell Responses Induced by a Norovirus P Particle Vaccine in Gnotobiotic Pigs.
    Kocher J; Castellucci TB; Wen K; Li G; Yang X; Lei S; Jiang X; Yuan L
    Pathogens; 2021 Jul; 10(7):. PubMed ID: 34357979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.
    Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V
    Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization.
    Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31684058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.
    Souza M; Costantini V; Azevedo MS; Saif LJ
    Vaccine; 2007 Dec; 25(50):8448-59. PubMed ID: 18022293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Mol Immunol; 2016 Oct; 78():27-37. PubMed ID: 27573255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevailing Sydney like Norovirus GII.4 VLPs induce systemic and mucosal immune responses in mice.
    Huo Y; Wan X; Ling T; Wu J; Wang Z; Meng S; Shen S
    Mol Immunol; 2015 Dec; 68(2 Pt A):367-72. PubMed ID: 26375574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective potency of Norovirus GII.17 virus-like particle-based vaccine.
    Chen W; Kang T; Yuan R; Shao C; Jing S
    Biotechnol Lett; 2020 Jul; 42(7):1211-1218. PubMed ID: 32088791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in mice.
    Kim SH; Chen S; Jiang X; Green KY; Samal SK
    J Virol; 2014 Sep; 88(17):9718-27. PubMed ID: 24920815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quadrivalent norovirus vaccine based on a chimpanzee adenovirus vector induces potent immunity in mice.
    Jiang Y; Sun L; Qiao N; Wang X; Zhu C; Xing M; Liu H; Zhou P; Zhou D
    Virol Sin; 2024 Aug; 39(4):675-684. PubMed ID: 38997087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30678195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.
    Tamminen K; Huhti L; Vesikari T; Blazevic V
    Viral Immunol; 2013 Apr; 26(2):167-70. PubMed ID: 23438469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Viral Immunol; 2016 Jun; 29(5):315-9. PubMed ID: 27135874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles.
    Tamminen K; Huhti L; Koho T; Lappalainen S; Hytönen VP; Vesikari T; Blazevic V
    Immunology; 2012 Jan; 135(1):89-99. PubMed ID: 22044070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.
    Debbink K; Lindesmith LC; Donaldson EF; Swanstrom J; Baric RS
    J Virol; 2014 Jul; 88(13):7256-66. PubMed ID: 24741081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.
    Yuan L; Geyer A; Hodgins DC; Fan Z; Qian Y; Chang KO; Crawford SE; Parreño V; Ward LA; Estes MK; Conner ME; Saif LJ
    J Virol; 2000 Oct; 74(19):8843-53. PubMed ID: 10982326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phylogenetic and biological characterizations of a GI.3 norovirus.
    Zheng L; Zhang H; Ma J; Liu J; Ma S; Wang M; Huo Y
    Infect Genet Evol; 2020 Nov; 85():104554. PubMed ID: 32927119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.